Wockhardt launches cardiac drug in United States
The Mumbai-based Wockhardt has launched cardiac drug, enalapril maleate, in the US market. The launch follows the expiry of Merck & Co's patents on the drug on August 22, 2000.

BSES plans major investments in power, telecom
Mumbai-based power utility BSES has planned major investments in generation, transmission, distribution and telecom. The company expects a 10 per cent increase in revenue and profit during the current fiscal, said chairman and managing director RV Shahi.

Tata Chem shareholders force poll on employee stock option scheme
Shareholders of Tata Chemicals, forced a poll on a special resolution for the introduction of an employee stock option scheme (ESOS). The shareholders' demand was in protest against the company for not having pursued its share buyback plans.


  Hughes Tele.com ties up Rs 1,078cr vendor debt
  Pizza Corner plans to raise Rs 23 crore for expansion
  Excel Ind to start chain of waste treatment plants
  Firestone's rivals seek share, but tyre price war likely to hurt stock
  Daewoo, Ford Motor on track for September sale
  China portal Sina.com holding talks for mergers
  Gail proposes to develop gas grid in Rajasthan
  The Index
  Briefing
  Tata Elxsi posts Rs 1.6cr netin first-quarter
  Mazda tries funky marketing strategy to lure Japan youth
  Daewoo, ABB pull out of Korba power project
  Ford's British arm told to improve work policy towards Indians, Blacks